Beta-cell response during a meal test: a comparative study of incremental doses of repaglinide in type 2 diabetic patients.

scientific article published in May 2005

Beta-cell response during a meal test: a comparative study of incremental doses of repaglinide in type 2 diabetic patients. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2337/DIACARE.28.5.1001
P698PubMed publication ID15855557
P5875ResearchGate publication ID7881629

P50authorStephen D. LuzioQ43227308
Gareth J DunseathQ56868243
P2093author name stringDavid R Owens
Paul M Underwood
Lawrence S Cozma
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)1001-1007
P577publication date2005-05-01
P1433published inDiabetes CareQ5270111
P1476titleBeta-cell response during a meal test: a comparative study of incremental doses of repaglinide in type 2 diabetic patients
P478volume28

Reverse relations

cites work (P2860)
Q33709590A review of treatment response in type 2 diabetes: assessing the role of patient heterogeneity
Q26829445Assessment of pancreatic β-cell function: review of methods and clinical applications
Q37416127Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial.
Q57951374Comparison of daytime 12-hour metabolic profiles after treatment with repaglinide and gliclazide in type 2 diabetes
Q45402322High molecular weight form of adiponectin levels of Japanese patients with chronic hepatitis C virus infection
Q37223610Indices of insulin sensitivity and secretion from a standard liquid meal test in subjects with type 2 diabetes, impaired or normal fasting glucose
Q28242989Meglitinide analogues: a review of clinical data focused on recent trials
Q37977979Repaglinide: a review of its use in type 2 diabetes mellitus
Q42873700Repeatability of Indices of Insulin Sensitivity and Secretion from Standard Liquid Meal Tests in Subjects with Type 2 Diabetes Mellitus or Normal or Impaired Fasting Glucose
Q53080005Treatment of young patients with HNF1A mutations (HNF1A-MODY).

Search more.